Brain47Brain47Join Brain47
21P

Aurora Cannabis Inc

Healthcare · EUR · F

21P

Price

€3.048

+0.53%

Cap

€279.08M

Earnings

—

30d Trend

+1.0%

21P
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

56% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level81
Quality49
Momentum20
Technical47
Fundamentals40

Raw weighted: 36×Macro 0.99 (−1%)=36

RISK

81/100
90d Volatility
56.2%High
ATR %
4.0%High daily moves
Max Drawdown (1Y)
-50.0%Volatile

QUALITY

49/100
ROE (avg)
-15.5%Negative
Piotroski F-Score
8/9Strong
Debt/Equity
0.18Low leverage
Margin Stability
CV 65.0%Volatile
Accruals
-1.7%Cash earnings
Interest Coverage
0.6xTight

MOMENTUM

20/100
12-1M Momentum
-45.8%Strong downtrend
6-1M Momentum
-33.5%Negative
1M Return
+12.2%Strong recent gains
Relative Strength
-0.1% vs sectorIn-line

TECHNICAL

47/100
RSI (14)
59.6Neutral
Price vs SMA200
-15.0%Bearish trend
MACD
+0.03Bullish momentum
Bollinger Band
113%Near upper band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.288Noisy/choppy

FUNDAMENTALS

40/100
EV/EBIT
49.7Expensive
P/S
0.7Cheap
Shareholder Yield
0.3%Low

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months ★61
3-12 months29
1-5+ years43

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate Aurora Cannabis Inc at 36/100 — a WEAK reading on the Brain47 Signal. The strongest factor is quality at 49/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+12.2%

3 MONTHS

-3.3%

12 MONTHS

-33.6%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Quality (49) and Technical (47) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 56%. I classify this as a speculative position — elevated volatility at 56% and smaller market cap define the opportunity.

speculativeScore: 36/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.